Niagen Bioscience, Inc. (NASDAQ:NAGE – Free Report) – Stock analysts at Roth Capital lowered their FY2026 earnings estimates for Niagen Bioscience in a research report issued on Wednesday, October 1st. Get Niagen Bioscience alerts:Niagen Bioscience (NASDAQ:NAGE – Get Free Report) last announced its earnings results on Wednesday, August 6th. Niagen Bioscience had a net margin of 15.24% and a return on equity of 23.12%. Weiss Ratings reissued a “hold (c)” rating on shares of Niagen Bioscience in a research report on Saturday, September 27th. Featured StoriesReceive News & Ratings for Niagen Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Niagen Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.